Standard Family Office’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-29
| Closed | -$6K | – | 29 |
|
|
2022
Q3 | $6K | Hold |
29
| – | – | ﹤0.01% | 285 |
|
|
2022
Q2 | $4K | Buy |
+29
| New | +$4K | 0.04% | 127 |
|
|
2022
Q1 | – | Sell |
-40
| Closed | -$7K | – | 82 |
|
|
2021
Q4 | $7K | Buy |
+40
| New | +$7K | 0.06% | 127 |
|
|
2021
Q3 | – | Sell |
-13
| Closed | -$2K | – | 88 |
|
|
2021
Q2 | $2K | Buy |
+13
| New | +$2K | ﹤0.01% | 335 |
|
|
2021
Q1 | – | Sell |
-11
| Closed | -$1K | – | 617 |
|
|
2020
Q4 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 530 |
|